
Share on:
ORTHOWORLD estimates that the global orthopedic market will grow 5% in 2024 to $62 billion, with the companies above accounting for nearly 70% of worldwide sales. They enter 2025 with various level of optimism for increased sales revenue and product innovation.
- Stryker is flourishing in a robust market that its leadership believes is the new normal for orthopedics.
- Johnson & Johnson MedTech hopes an evolving technology portfolio generate some positive momentum.
- Zimmer Biomet has a chance to differentiate itself through its expanding technology ecosystem.
- Smith+Nephew’s recon business saw positive growth due to better supply and commercial execution and the continued adoption of the CORI robotic system.
- Medtronic is betting that its AiBLE digital ecosystem will continue to fuel the company’s success in spine.
- Arthrex wants to integrate its visualization cameras and endoscopes into the advancement of endoscopic spine surgery.
- Globus Medical sees a slightly higher ceiling for spine market growth over the long-term.
- Enovis believes it has a foot and ankle pipeline that can drive double-digit growth.
It will be interesting to watch the performance of these companies as the year progresses and the orthopedic market continues its single-digit growth.
The infographic is proudly sponsored by Intech, your premier vertically integrated design and manufacturing partner dedicated to orthopedics.
RELATED ARTICLES
Nelipak Healthcare Packaging Expands in Asia-Pacific Region
Apr 07 2025 , Julie A. Vetalice
Oxford Performance Materials Enters Distribution Partnership with Sovereign
Apr 07 2025 , Julie A. Vetalice